Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEGON LTD. Regulatory Filings 2017

Mar 27, 2017

30489_rns_2017-03-27_e1fde850-bb4a-41b7-9172-01e5971dbcad.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

IRANNOTICE 1 d303619dirannotice.htm IRANNOTICE IRANNOTICE

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

USA

Handled by Our reference The Hague
J.O. van Klinken M/LEGL/KKN March 27, 2017
Telephone +31 70 344 73 08

Re: Notice of disclosure filed in Securities Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

Ladies and Gentlemen:

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Aegon N.V. has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2016, which was filed with the Securities and Exchange Commission on March 24, 2017. The disclosure can be found under the heading “Compliance with regulations” in the Annual Report on Form 20-F and is incorporated by reference herein.

Sincerely,

/s/ J.O. van Klinken

J.O. van Klinken

General Counsel

Aegon N.V. Aegonplein 50 PO Box 85
T +31 70 344 32 10 2591 TV The Hague 2501 CB The Hague
| www.aegon.com The Netherlands The Netherlands Registered seat in The Hague, trade register number 27076669